Literature DB >> 15035781

Time-course evaluation of whole blood phagocytosis in mice treated with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Haseeb Ahmad Khan1.   

Abstract

Immunological abnormalities have been described in idiopathic Parkinson's disease and in the mouse model of this disorder induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). This investigation was aimed to study the effect of MPTP on inflammatory response of whole blood phagocytes at different time intervals. C57BL male mice were injected intraperitoneally with either MPTP (30 mg/kg) or saline (control group) and the blood samples were collected at 4, 24 and 48 h. 50 microl of a 500-fold diluted blood sample was mixed with 150 microl of reaction mixture (0.4 mM luminol + 50 microg opsonized zymosan + 0.1% gelatin, in Hanks' balanced salt solution) and the chemiluminescence (CL) signal was measured in a luminometer at 37 degrees C. Although the CL response of the whole blood from control and MPTP groups was similar at 4 h, a significant increase in the CL signal was observed in MPTP-treated mice at 24 h post-treatment, which got subsided at 48 h. The findings of this study suggest that in an early stage a pro-inflammatory response following MPTP might trigger a chain of potentially toxic pathways mediated by reactive oxygen species, leading to progressive neuronal damage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15035781     DOI: 10.1163/156856004773121392

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  41 in total

1.  NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Authors:  Du-Chu Wu; Peter Teismann; Kim Tieu; Miquel Vila; Vernice Jackson-Lewis; Harry Ischiropoulos; Serge Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

2.  Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  T P Singer; N Castagnoli; R R Ramsay; A J Trevor
Journal:  J Neurochem       Date:  1987-07       Impact factor: 5.372

3.  Co-oxidation of luminol by hypochlorite and hydrogen peroxide implications for neutrophil chemiluminescence.

Authors:  E P Brestel
Journal:  Biochem Biophys Res Commun       Date:  1985-01-16       Impact factor: 3.575

4.  [The effect of catecholamines on the luminol-dependent chemiluminescence of rat polymorphonuclear leukocytes].

Authors:  M M Potselueva; B S Marinov; A V Pustovidko; L Iu Kudzina; Iu V Evtodienko
Journal:  Tsitologiia       Date:  1997

5.  Sodium diethyldithiocarbamate protects against the MPTP-induced inhibition of immune responses in mice.

Authors:  G Renoux; K Bizière; M Renoux; R Steinberg; J P Kan; J M Guillaumin
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

6.  Comparison of the effects of superoxide dismutase and cytochrome c on luminol chemiluminescence produced by xanthine oxidase-catalyzed reactions.

Authors:  R A Radi; H Rubbo; E Prodanov
Journal:  Biochim Biophys Acta       Date:  1989-01-19

7.  Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion.

Authors:  T B McCall; N K Boughton-Smith; R M Palmer; B J Whittle; S Moncada
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

Review 8.  Pathogenic role of glial cells in Parkinson's disease.

Authors:  Peter Teismann; Kim Tieu; Oren Cohen; Dong-Kug Choi; Du Chu Wu; Daniel Marks; Miquel Vila; Vernice Jackson-Lewis; Serge Przedborski
Journal:  Mov Disord       Date:  2003-02       Impact factor: 10.338

9.  Neuronal degeneration and microglial reaction in the fetal and postnatal rat brain after transient maternal hypoxia.

Authors:  Y B Li; C Kaur; E A Ling
Journal:  Neurosci Res       Date:  1998-10       Impact factor: 3.304

10.  The origin of chemiluminescence produced by neutrophils stimulated by opsonized zymosan.

Authors:  K Cheung; A C Archibald; M F Robinson
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.